Renal disease. II.

Urotensin II and cardiomyopathy in end-stage renal disease.

Circulating urotensin (UTN) is increased in patients with heart failure and in patients with renal diseases, and UTN antagonism is currently considered as a potential treatment for these conditions. Contrary to this contention, studies in end-stage renal disease suggest that, perhaps because of interference with sympathetic and NO systems, UTN may be cardioprotective. Therefore, we investigated...

Bardet-Biedl Syndrome with End Stage Renal Disease

Bardet-Biedl syndrome (BBS) is one of the rare autosomal recessive disorders that affect multiple organs of the body. The signs and symptoms of this condition vary among affected individuals, even among members of the same family. We present a case of BBS with features of hypogonadism and features such as marked central obesity, retinitis pigmentosa, polydactyly, renal abnormalities and mental ...

Atherosclerotic Peripheral Vascular Disease Symposium II: intervention for renal artery disease.

The primary goal of this American Heart Association renal intervention writing group was to discuss current controversies related to renal interventions and to recommend important areas of clinical research and advocacy initiatives in this peripheral arterial bed. The 4 areas covered in this section include (1) management of asymptomatic renal artery disease, (2) treatment of ischemic nephropat...

Renal Disease

Renal Disease *

The title of this talk is extremely broad. Obviously I cannot pretend to cover the field of renal disease in a single lecture. All I intend is to express a point of view and to suggest an attitude or approach to the subject. Attention will be directed particularly to those diseases that lead to deterioration of the function of the kidneys accompanied by vascular disorders , especially hypertens...